Allergy, Asthma & Clinical Immunology (Mar 2022)
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network
Abstract
Key messages 1. The JMCN has steadily and substantially grown for more than 2 decades and continues to significantly influence the global Immunology community. 2. In addition to compiling an extensive global patient database, the expanding JMCN acts as a unique and critical resource, increasing awareness of PIs, educating physicians and patients, and facilitating diagnosis via expertise and genetic sequencing, as well as treatment. 3. The JMCN provides a platform to optimize research advances, earliest diagnosis, enhanced treatments, and implement standard-of-care and best practices through maximized connectivity, resulting in a better quality of life and improved outcomes for patients with PI.
Keywords